351
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

Surfactant-free amorphous solid dispersion with high dissolution for bioavailability enhancement of hydrophobic drugs: a case of quercetin

, , , , , , & show all
Pages 153-162 | Received 23 Jul 2020, Accepted 28 Nov 2020, Published online: 15 Feb 2021

References

  • Shi Q , Moinuddin SM , Cai T. Advances in coamorphous drug delivery systems. Acta Pharm Sin B. 2019;9(1):19–35.
  • Wu W , Lobmann K , Rades T , et al. On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems. Int J Pharm. 2018;535(1–2):86–94.
  • Hsu CM , Yu SC , Tsai FJ , et al. Characterization of in vitro and in vivo bioactivity of a ferulic acid-2-Hydroxypropyl-β-cyclodextrin inclusion complex. Colloids Surf B Biointerfaces. 2019;180:68–74.
  • Ahmed S , Corvis Y , Gahoual R , et al. Conception of nanosized hybrid liposome/poloxamer particles to thicken the interior core of liposomes and delay hydrophilic drug delivery. Int J Pharm. 2019;567:118488.
  • Hou G , Wang Z , Ma H , et al. High-temperature stable plasmonic and cavity resonances in metal nanoparticle-decorated silicon nanopillars for strong broadband absorption in photothermal applications. Nanoscale. 2019;11(31):14777–14784.
  • Trubitsyn G , Nga Nguyen V , Di Tommaso C , et al. Impact of covalently nile red and covalently rhodamine labeled fluorescent polymer micelles for the improved imaging of the respective drug delivery system. Eur J Pharm Biopharm. 2019;142:480–487.
  • Suzuki H , Yakushiji K , Matsunaga S , et al. Amorphous solid dispersion of meloxicam enhanced oral absorption in rats with impaired gastric motility. J Pharm Sci. 2018;107(1):446–452.
  • Abdulkarim M , Sharma PK , Gumbleton M. Self-emulsifying drug delivery system: mucus permeation and innovative quantification technologies. Adv Drug Deliv Rev. 2019;142:62–74.
  • Sverdlov Arzi R , Sosnik A. Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals. Adv Drug Deliv Rev. 2018;131:79–100.
  • Wang R , Han J , Jiang A , et al. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine. Int J Pharm. 2019;561:9–18.
  • Indulkar AS , Waters JE , Mo H , et al. Origin of nanodroplet formation upon dissolution of an amorphous solid dispersion: a mechanistic isotope scrambling study. J Pharm Sci. 2017;106(8):1998–2008.
  • Shi X , Song S , Ding Z , et al. Improving the solubility, dissolution, and bioavailability of ibrutinib by preparing it in a coamorphous state with saccharin. J Pharm Sci. 2019;108(9):3020–3028.
  • Fan W , Zhu W , Zhang X , et al. Application of the combination of ball-milling and hot-melt extrusion in the development of an amorphous solid dispersion of a poorly water-soluble drug with high melting point. RSC Adv. 2019;9(39):22263–22273.
  • Liu C , Liu Z , Chen Y , et al. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion. Eur J Pharm Biopharm. 2018;124:73–81.
  • Miao L , Liang Y , Pan W , et al. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion. Drug Deliv Transl Res. 2019;9(1):344–356.
  • Hernandez-Patlan D , Solis-Cruz B , Pontin KP , et al. Evaluation of a solid dispersion of curcumin with polyvinylpyrrolidone and boric acid against salmonella enteritidis infection and intestinal permeability in broiler chickens: a pilot study. Front Microbiol. 2018;9:1289.
  • Takeuchi I , Shimakura K , Kuroda H , et al. Estimation of crystallinity of nifedipine-polyvinylpyrrolidone solid dispersion by usage of terahertz time-domain spectroscopy and of x-ray powder diffractometer. J Pharm Sci. 2015;104(12):4307–4313.
  • Otto DP , Otto A , de Villiers MM. Experimental and mesoscale computational dynamics studies of the relationship between solubility and release of quercetin from PEG solid dispersions. Int J Pharm. 2013;456(2):282–292.
  • Hu L , Shi Y , Li JH , et al. Enhancement of oral bioavailability of curcumin by a novel solid dispersion system. AAPS PharmSciTech. 2015;16(6):1327–1334.
  • Gilley AD , Arca HC , Nichols BLB , et al. Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro. Carbohydr Polym. 2017;157:86–93.
  • Deng Y , Liang Q , Wang Y , et al. The inhibiting role of hydroxypropylmethylcellulose acetate succinate on piperine crystallization to enhance its dissolution from its amorphous solid dispersion and permeability. RSC Adv. 2019;9(67):39523–39531.
  • Solanki NG , Lam K , Tahsin M , et al. Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: miscibility and drug release. J Pharm Sci. 2019;108(4):1453–1465.
  • Sun DD , Lee PI. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. J Control Release. 2015;211:85–93.
  • Chavan RB , Thipparaboina R , Kumar D , et al. Co amorphous systems: a product development perspective. Int J Pharm. 2016;515(1–2):403–415.
  • Al-Jamal O , Al-Jighefee H , Younes N , et al. Organ-specific toxicity evaluation of stearamidopropyl dimethylamine (SAPDMA) surfactant using zebrafish embryos. Sci Total Environ. 2020;741:140450.
  • Zhang D , Ye D , Jing P , et al. Design, optimization and evaluation of co-surfactant free microemulsion-based hydrogel with low surfactant for enhanced transdermal delivery of lidocaine. Int J Pharm. 2020;586:119415.
  • Chistyachenko YS , Dushkin AV , Polyakov NE , et al. Polysaccharide arabinogalactan from larch Larix sibirica as carrier for molecules of salicylic and acetylsalicylic acid: preparation, physicochemical and pharmacological study. Drug Deliv. 2015;22(3):400–407.
  • Takeda K , Gotoda Y , Hirota D , et al. Surfactant-free solid dispersions of hydrophobic drugs in an amorphous sugar matrix dried from an organic solvent. Mol Pharm. 2017;14(3):791–798.
  • Takeda K , Sekitoh T , Fujioka A , et al. Physical stability of an amorphous sugar matrix dried from methanol as an amorphous solid dispersion carrier and the influence of heat treatment. J Pharm Sci. 2019;108(6):2056–2062.
  • Jung WJ , Park RD. Bioproduction of chitooligosaccharides: present and perspectives. Mar Drugs. 2014;12(11):5328–5356.
  • Muanprasat C , Chatsudthipong V. Chitosan oligosaccharide: biological activities and potential therapeutic applications. Pharmacol Ther. 2017;170:80–97.
  • Phil L , Naveed M , Mohammad IS , et al. Chitooligosaccharide: an evaluation of physicochemical and biological properties with the proposition for determination of thermal degradation products. Biomed Pharmacother. 2018;102:438–451.
  • Wang G , Chen Y , Wang P , et al. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Acta Biomater. 2016;29:248–260.
  • Wang JJ , Zeng ZW , Xiao RZ , et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine. 2011;6:765–774.
  • Zhou W , Shan J , Tan X , et al. Effect of chito-oligosaccharide on the oral absorptions of phenolic acids of Flos Lonicerae extract. Phytomedicine. 2014;21(2):184–194.
  • Zhou W , Tan X , Shan J , et al. Effect of chito-oligosaccharide on the intestinal absorptions of phenylethanoid glycosides in Fructus Forsythiae extract. Phytomedicine. 2014;21(12):1549–1558.
  • Wegiel LA , Mauer LJ , Edgar KJ , et al. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions. J Pharm Pharmacol. 2014;66(2):244–255.
  • Andres S , Pevny S , Ziegenhagen R , et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62(1):1700447.
  • Patel RV , Mistry BM , Shinde SK , et al. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018;155:889–904.
  • Carullo G , Cappello AR , Frattaruolo L , et al. Quercetin and derivatives: useful tools in inflammation and pain management. Future Med Chem. 2017;9(1):79–93.
  • Penalva R , Gonzalez-Navarro CJ , Gamazo C , et al. Zein nanoparticles for oral delivery of quercetin: pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia. Nanomedicine. 2017;13(1):103–110.
  • Zheng Y , Haworth IS , Zuo Z , et al. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes. J Pharm Sci. 2005;94(5):1079–1089.
  • Kumar P , Sharma G , Kumar R , et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences. Int J Pharm. 2016;515(1–2):307–314.
  • Penalva R , Esparza I , Morales-Gracia J , et al. Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin. Int J Pharm. 2019;570:118652.
  • Krupa A , Descamps M , Willart JF , et al. High-energy ball milling as green process to vitrify tadalafil and improve bioavailability. Mol Pharm. 2016;13(11):3891–3902.
  • Han J , Wei Y , Lu Y , et al. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update. Expert Opin Drug Deliv. 2020 17(10):1411–1435.;
  • Liu X , Xia W , Jiang Q , et al. Synthesis, characterization, and antimicrobial activity of kojic acid grafted chitosan oligosaccharide. J Agric Food Chem. 2014;62(1):297–303.
  • Qian S , Heng W , Wei Y , et al. Coamorphous lurasidone hydrochloride–saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior. Cryst Growth Des. 2015;15(6):2920–2928.
  • Schver G , Lee PI. Combined effects of supersaturation rates and doses on the kinetic-solubility profiles of amorphous solid dispersions based on water-insoluble poly(2-hydroxyethyl methacrylate) hydrogels. Mol Pharm. 2018;15(5):2017–2026.
  • Huang R , Han J , Wang R , et al. Surfactant-free solid dispersion of BCS class IV drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro – permeability increase. Eur J Pharm Sci. 2019;130:147–155.
  • Fong SY , Bauer-Brandl A , Brandl M. Oral bioavailability enhancement through supersaturation: an update and meta-analysis. Expert Opin Drug Deliv. 2017;14(3):403–426.
  • Frank KJ , Westedt U , Rosenblatt KM , et al. What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci. 2014;103(6):1779–1786.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.